University Hospital Of North Norway
Clinical trials sponsored by University Hospital Of North Norway, explained in plain language.
-
Could a few doses of ketamine help both depression and alcohol addiction?
Disease control Recruiting nowThis study investigates whether ketamine, given as four intravenous infusions over two weeks, can reduce depression and alcohol cravings in adults who have both conditions. Participants are already in inpatient addiction therapy and are randomly assigned to receive either ketamin…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital of North Norway • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Remote CT scans could speed up stroke treatment in rural areas
Disease control Recruiting nowThis study tests whether using remote-controlled CT scans at local medical centers, guided by a hospital stroke team via video call, can speed up treatment for stroke patients. About 52 participants with suspected stroke will be randomly assigned to either this new approach or st…
Phase: NA • Sponsor: University Hospital of North Norway • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Tailored meals may boost recovery in ICU patients
Disease control Recruiting nowThis study tests whether personalized nutrition from a dietitian helps critically ill patients get more energy and protein during and after their ICU stay. Researchers will compare usual care with a tailored plan for 300 adults over 6 months. The goal is to see if this approach i…
Phase: NA • Sponsor: University Hospital of North Norway • Aim: Disease control
Last updated Jun 26, 2026 12:58 UTC
-
AI and PET scans could replace needle biopsies for prostate cancer grading
Diagnosis Recruiting nowThis study tests whether combining PSMA PET scans with machine learning can accurately grade prostate cancer without invasive biopsies. Researchers will enroll 220 men with suspected or confirmed prostate cancer. If successful, this approach could reduce unnecessary biopsies and …
Sponsor: University Hospital of North Norway • Aim: Diagnosis
Last updated Jun 27, 2026 08:02 UTC
-
Could a gut makeover help Alzheimer's? first safety trial begins
Symptom relief Recruiting nowThis early-stage study is testing whether a fecal microbiota transplant (FMT) is safe and feasible for people with mild-to-moderate Alzheimer's disease. Ten participants will receive the transplant via colonoscopy, and researchers will monitor side effects, recruitment rates, and…
Phase: PHASE1 • Sponsor: University Hospital of North Norway • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New tool aims to slash months-long thyroid dose adjustment to weeks
Symptom relief Recruiting nowThis study tests a decision support tool that uses blood samples from the first two weeks after thyroid surgery to predict the best levothyroxine dose. Normally, dose adjustments take months of trial and error. The trial will enroll 240 patients and compare the tool's guidance to…
Phase: NA • Sponsor: University Hospital of North Norway • Aim: Symptom relief
Last updated Jun 26, 2026 16:45 UTC
-
Heart monitor by post could cut stroke risk, major study hopes
Knowledge-focused Recruiting nowThis study is testing whether sending a portable ECG monitor to people with elevated NT-proBNP (a heart stress marker) can catch hidden atrial fibrillation and reduce strokes. 4,000 adults aged 40+ without known AF will be randomly assigned to either 7 days of home monitoring or …
Phase: NA • Sponsor: University Hospital of North Norway • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC